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Abstract
Background: Asplenic individuals are susceptible for overwhelming infection with Streptococcus pneumoniae,
carrying a high mortality. Although Toll-like receptor (TLR)-2 is considered the major receptor for Gram-positive
bacteria in innate immunity, it does not play a major role in host defense against pneumococcal pneumonia.
We wanted to investigate if in absence of an intact spleen as a first line of defense, the role of TLR2 during
pneumococcal pneumonia becomes more significant, thereby explaining its insignificant role during infections
in immune competent hosts.
Methods: We intranasally infected splenectomized wildtype (WT), TLR2 knock-out (KO) and TLR2/4 double KO
mice with either serotype 2 or 3 S. pneumoniae.
Results: There were no differences between asplenic WT and TLR2KO mice of bacterial loads in lung homogenates
and blood, cytokine and chemokine levels in the lungs, and lung pathology scores. TLR2/4 double KO mice were
not impaired in bacterial control as well, which indicates that besides the interaction between S. pneumoniae and
TLR2, the interaction between pneumolysin and TLR4 does not stimulate antibacterial defense in the asplenic host
either.
Conclusions: These results argue against a significant role of TLR2 in host defense during S. pneumoniae
pneumonia in the asplenic state. Therefore, other components can provide sufficient backup mechanisms for
TLR2 deficiency in the defense against intrapulmonary infections with S. pneumoniae of the otherwise immune
competent host.
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Background
Streptococcus pneumoniae is the most frequently isolated
pathogen in community acquired pneumonia [1,2].
Virtually all clinical S. pneumoniae isolates contain an
external capsule consisting of repeating oligosaccharides.
Based on antigenic differences in capsular polysacchar-
ides, over 90 different serotypes of S. pneumoniae have
been described. The capsule is the bacterium’s most
important virulence factor, enabling the pathogen to
evade recognition and phagocytosis by the host immune
system [3,4]. In the host response to infection, the innate
immune system mediates the first line of defense against
invading pathogens, prior to the induction of the adap-
tive immune response. The family of Toll-like receptors
(TLRs) prominently features in the innate immune
system [5,6]. At present, 12 murine TLRs and 10 human
TLRs have been identified. Each TLR recognizes distinct
components of pathogens, referred to as pathogen-
associated molecular patterns (PAMPs), thus composing
an efficient way of sensing microorganisms [7]. Inter-
action of such a PAMP with a TLR is followed by a com-
plex cascade of intracellular signalling, which leads to a
proinflammatory response [5].
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TLR2 has been designated the major receptor for
Gram-positive bacteria since it signals the presence of
lipoteichoic acid (LTA), peptidoglycan and lipopeptides,
which are all components of the Gram-positive cell wall
[5,6]. In accordance, viable and heat killed S. pneumo-
niae are primarily recognized by TLR2 [8,9] and TLR2
knockout (KO) mice did not develop airway inflamma-
tion upon intrapulmonary delivery of pneumococcal
LTA in vivo [10]. Nonetheless, our laboratory and others
have demonstrated that TLR2 does not play a major role
in host defense against pneumococcal pneumonia [8,11,
12]. Indeed, although TLR2KO mice displayed modestly
reduced lung inflammation upon intranasal infection
with S. pneumoniae, bacterial loads and mortality did
not differ between TLR2KO and wild-type (WT) mice
after intranasal inoculation with a wide range of infec-
tious doses [8,11,12]. Furthermore, TLR2 did not
contribute to an effective antibacterial defense during
post-influenza pneumococcal pneumonia [13], which
normally is associated with a much stronger inflamma-
tory response in the lungs than primary pneumonia [14].
Together, these results suggest that other – TLR2 inde-
pendent - components of host defense are sufficient to
maintain an adequate immune response during respira-
tory tract infection caused by S. pneumoniae.
The spleen has an important role in innate as well as
adaptive immunity. Especially the splenic marginal zone
(MZ) is of great importance in innate immunity, since it
contains MZ-macrophages and specific IgM-memory B
cells that are capable of mounting a direct immune
response against encapsulated bacteria such as S. pneu-
moniae, independently of the adaptive immune system
[15,16]. Asplenia in humans is associated with an
increased risk for lethal infections especially with S.
pneumoniae [17-19], and multiple experimental studies
have demonstrated that asplenic animals display a mark-
edly impaired host defense response after infection with
pneumococci as well [15,20-22].
Earlier investigations examined the role of TLRs in the
interaction between splenocytes and S. pneumoniae.
Incubation of WT splenocytes with intact S. pneumoniae
rapidly induced TLR-dependent production of pro-
inflammatory cytokines in the spleen [23]: deficiency
of Myeloid differentiation primary response gene-88
(MyD88) adaptor protein, which signals all TLRs except
TLR3, resulted in a complete loss of splenic cytokine
and chemokine mRNA induction upon exposure to
heat-killed S. pneumoniae in vitro. Notably, although
other single TLRKO mice did not show reduced cyto-
kine production, TLR2KO mice did have a loss of TNF-
α and IL-1β secretion by macrophages and dendritic
cells of the spleen [23]. After intraperitoneal injection
of heat-killed pneumococci in vivo, however, TLR2KO
mice displayed unaltered proinflammatory cytokine gene
expression in their spleens, whereas MyD88KO mice
had virtually completely lost their ability to mount a
splenic cytokine response [24]. In contrast to its appar-
ent insignificant role in the innate immune response
in the spleen, TLR2 was shown to be important for
the induction of a type 1 humoral immune response,
as reflected by strongly diminished IgG3, IgG2a and
IgG2b production in TLR2KO mice after intraperitoneal
S. pneumoniae administration [24]. These findings sug-
gest that the TLR2 mediated immune response during
pneumococcal infection might partially be dependent on
the spleen as an effector organ.
We here argued that in absence of an intact spleen as
a first line of defense, the role of TLR2 during pneumo-
coccal pneumonia becomes more important, thereby
explaining the insignificant role for this pattern recogni-
tion receptor during respiratory tract infection by S.
pneumoniae in the otherwise immune competent host.
Therefore, to further elicit the role of TLR2, in the
present study we compared the host response in sple-
nectomized TLR2KO and WT mice after infection
with encapsulated (serotype 2 and 3) S. pneumoniae via
the airways.
Methods
Animals
Specific pathogen-free, 8–10 week old, C57BL/6 WT
mice were purchased from Charles River (Maastricht,
The Netherlands). TLR2KO mice (kindly provided by
Shizuo Akira, Exploratory Research for Advanced Tech-
nology, Japan Science and Technology Agency, Suita,
Osaka, Japan) were generated as described previously
[25] and backcrossed to C57BL/6 background 6 times.
TLR2/4 double KO mice were generated by crossing
TLR2 [25] and TLR4KO mice [26], both backcrossed 6
times to a C57BL/6 background. All mice were bred in
the animal facility of the Academic Medical Center in
Amsterdam. In all experiments, male, age matched
mice were used. All experiments were approved by the
Animal Care and Use Committee of the University of
Amsterdam (Amsterdam, Netherlands).
Splenectomy
Mice were given buprenorphine (TemgesicW, Schering-
Plough, Amstelveen, Netherlands) 0.075 mg/kg subcuta-
neously 15 minutes preoperatively, and anesthetized via
inhalation of a mixture of O2 (1–2 l/min) and isoflurane
2.0-2.5% (Abbott, Kent, UK). A 1 cm incision was made
in the left flank and peritoneum and the spleen was
mobilized. In sham operated (Sham) mice the spleen
was replaced. Splenectomy was performed after separ-
ately ligating the efferent and afferent vessels with Sof-
silk 4–0 (Tyco Healthcare Group, Connecticut). 1 ml
sterile saline was administered for fluid resuscitation in
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the abdominal cavity, and peritoneum and skin were closed
with Vicryl 4–0 (Ethicon, Johnson&Johnson, Belgium).
After 8 hours 0.05 mg/kg buprenorphine was administered.
Mice were given a period of 2 weeks to recover after sur-
gery before infection with S. pneumoniae.
Bacteria
The S. pneumoniae strains used in this study were WT
isolates D39 (serotype 2) and ATCC 6303 (American
Type Culture Collection, Rockville, MD; serotype 3).
Experimental design
Both S. pneumoniae strains were grown for 3–6 hours to
mid-logarithmic phase at 37°C using Todd-Hewitt broth
(Difco, Detroit, MI), supplemented with yeast extract
(0.5%). Bacteria were harvested by centrifugion at
4000 rpm, and washed twice in sterile isotonic saline.
For induction of pneumonia, bacteria were administered
intranasally (total volume 50 μl) under light anaesthesia
by inhalation of isoflurane (Abbott, Kent, UK) as
described previously [27,28]. Infectious doses were as
described in the Results section and table/figure legends.
For determining bacterial loads, mice were sacrificed
under isoflurane anaesthesia (2%/2 L) and samples were
collected and processed as described [27,28]. Briefly,
lungs and liver were homogenized at 4°C in 5 volumes
of sterile isotonic saline with a tissue homogenizer (Bios-
pect Products, Bartlesville, OK). Homogenates and blood
were serially diluted 10-fold in sterile isotonic saline, and
50 μl volumes were plated onto sheep-agar plates and
incubated over night at 37°C when colony forming units
(CFU) were counted. Lung and liver homogenates were
prepared for cytokine measurements in lysis buffer con-
taining 300 mM NaCl, 30 mM Tris, 2 mM MgCl2.6H2O,
2 mM CaCl2.2H2O and 1% Triton X-100 (pH 7.4) with
0.5 ml protease-inhibitor (Roche Complete, 1 tablet
protease inhibitor in 5 ml demi-water), incubated
for 20 min. at 4°C, centrifuged at 3600 rpm for 10 min.
and supernatants were stored at −20°C until assays
were performed.
Assays
Lung cytokines and chemokines (TNF-α, keratinocyte chemo-
attractant (KC/CXCL1), interleukin (IL)-1β and macrophage
inflammatory protein 2 (MIP-2/CXCL2) were measured
using specific ELISAs (R&D Systems, Minneapolis, MN)
according to the manufacturers’ instructions.
Histology
Lungs for histology were fixed in 4% formalin and
embedded in paraffin. Five μm sections were stained
with hematoxylin and eosin (HE). All slides were ana-
lyzed by a pathologist blinded for groups. To score lung
inflammation and damage, the entire lung surface was
analyzed with respect to the following parameters: bron-
chitis, edema, interstitial inflammation, intra-alveolar
inflammation, pleuritis and endothelialitis. Each param-
eter was graded on a scale of 0 to 4, with 0 being ‘absent’
and 4 being ‘severe’. Total ‘lung inflammation score’
(TLIS) was expressed as the sum of the scores for each
parameter, the maximum being 24. Granulocyte staining
was done using FITC-labeled rat anti-mouse Ly-6 mAb
(Pharmingen, San Diego, CA) as described earlier [8].
The entire lung surface was analyzed for Ly-6 G inten-
sity by Image J (U.S. National Institutes of Health,
Bethesda, MD, http://rsb.info.nih.gov/ij).
Statistical analysis
Statistics were performed with GraphPad Prism version
4.00 for Windows, GraphPad Software, San Diego CA.
Data are given as scatterplots or as means ± SEM.
Differences between groups were analyzed using
Mann–Whitney U test. For survival analyses, Kaplan-
Meier analysis, followed by a log rank test, was per-
formed at different time points for the proportion of
survivors. A value of p< 0.05 was considered statisti-
cally significant.
Results
TLR2 does not contribute to host defense during
pneumonia caused by serotype 2 S. pneumoniae in
splenectomized mice
In otherwise immune competent mice, TLR2 deficiency
does not influence mortality or bacterial growth during
pneumococcal pneumonia [8,11,12]. We here investi-
gated the impact of TLR2 on the outcome of pneumonia
in splenectomized mice. For this purpose we infected
WT and TLR2KO mice two weeks after splenectomy
with S. pneumoniae D39 intranasally, at a dose known to
be nonlethal to normal WT mice (5 x 105 CFU) [12] and
followed them for 1 week (Figure 1A). Although initially
TLR2KO mice had a minor survival advantage, mortality
did not significantly differ between WT and TLR2KO
mice. We next determined bacterial loads in whole lung
homogenates and blood at 6 and 24 hours after infec-
tion, i.e. at time points before the first mice started to
die (Figure 1B). At both 6 and 24 hours, bacterial loads
were identical in the lungs of WT and TLR2KO mice.
In addition, the extent of dissemination of the infection
did not differ between the two mouse strains: blood cul-
tures were positive in 2 of 6 WT mice and 1 of 6 KO
mice at 6 hours, at 24 hours after infection 4 of 7 WT
mice and 5 of 6 TLR2KO mice had positive blood cul-
tures (data not shown). These data demonstrate that
even in the absence of a functional spleen TLR2 does
not contribute to a protective immune response during
pneumonia caused by a serotype 2 pneumococcus.
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TLR2 does not contribute to the inflammatory response
during pneumonia caused by serotype 2 S. pneumoniae
in splenectomized mice
Cytokines and chemokines are important in the antibac-
terial defense against S. pneumoniae pneumonia [2].
After splenectomy, an imbalance in cytokines has been
proposed as possible mechanism for enhanced suscepti-
bility to pneumococcal infections [29]. To investigate the
role of TLR2 in the pulmonary inflammatory response
in the asplenic host, we determined the concentrations
of TNF-α, IL-1β, MIP-2 and KC in whole lung homoge-
nates obtained at 6 and 24 hours after inoculation
(Table 1). Except for MIP-2 at 6 hours after infection,
there were no significant differences in the pulmonary
levels of these mediators between TLR2KO and WT
mice. To obtain further insight into a possible role of
TLR2 in lung inflammation during pneumococcal pneu-
monia in splenectomized animals, we prepared lung
tissue slides from TLR2KO and WT mice 6 and 24
hours after infection and determined semi-quantitative
scores of specific histological alterations characteristic
for bacterial pneumonia. These analyses showed a minor
trend towards lower levels of lung pathology in TLR2KO
mice at both time points, albeit non-significant. The
extent of Ly-6 G positivity, indicating neutrophil influx,
was similar in both mouse strains (Figure 2). Together,
these data suggest that TLR2 does not contribute to the
host response during serotype 2 S. pneumoniae pneumo-
nia in splenectomized mice.
TLR2 does not contribute to antibacterial defense during
pneumonia caused by serotype 3 S. pneumoniae in
splenectomized mice
To obtain further proof for an insignificant role of TLR2
during pneumococcal pneumonia in the asplenic host,
we repeated part of the experiments described above
with a serotype 3 S. pneumoniae (ATCC6303). For this
purpose we intranasally infected TLR2KO and WT mice
that had been splenectomized two weeks earlier with 7 x
104 CFU S. pneumoniae ATCC6303, i.e. a dose expected
to cause mortality in WT mice beyond the 24-hour time
point [8,28] and determined bacterial loads in whole
lung homogenates and blood 24 hours later. Similar to
the experiments with the serotype 2 strain, there were
no differences in bacterial loads in the lungs of WT and
TLR2KO mice (Figure 3). In addition, bacterial loads in
blood were not significantly different between groups;
4 of 7 WT mice had positive blood cultures compared
to 6 of 8 TLR2KO mice (data not shown). Moreover,
except for MIP-2, concentrations of TNF-α, IL-1β and
KC in the lung homogenates obtained 24 hours after
infection with serotype 3S. pneumoniae were not signifi-
cantly different between WT and TLR2KO mice (Table 2).
Lung pathology however, as reflected by total lung in-
flammation score, was significantly lower in TLR2KO
mice as compared to WT mice (Figure 4); lungs of WT
mice in general showed higher levels of interstitial
inflammation, endothelialitis and pleuritis, whereas in
KO mice there was less lung edema. This is in accord-
ance with lower levels of lung pathology in TLR2KO
mice infected with serotype 2 S. pneumonia. Neutrophil
influx into the lungs, as reflected by percentages of
Table 1 Lung cytokine and chemokine levels in
splenectomized WT and TLR2KO mice, 6 and 24 h after
infection with serotype 2 S. pneumoniae
6 h 24 h
WT TLR2KO WT TLR2KO
TNF-α 1581 ± 268 1376± 190 1290± 49 1515± 249
IL-1β 173,5 ± 37 249,9 ± 91 132,9 ± 26 186,7 ± 35
MIP-2 2110 ± 333 4172± 919 * 951,6 ± 69 798,8 ± 53
KC 1244 ± 254 2680± 1825 1292± 241 1548± 263
Whole lung homogenates were obtained at 6 and 24 hours after intranasal
infection with 6*105 CFU of S. pneumoniae serotype 2 (D39). Data are
means ± SEM (N= 6–7 per group).
* indicates p< 0.05 versus WT mice. TNF-α, IL-1β, MIP-2 and KC values are in
pg/ml.
Figure 1 TLR2 does not contribute to host defense against serotype 2 S. pneumoniae after splenectomy. Survival (1A) and bacterial
outgrowth (1B) of WT mice and TLR2KO mice. Mortality was assessed two times per day after infection with 5*105 CFU of S. pneumoniae (D39),
for 1 week (8 WT versus 7 KO mice). Bacterial loads were determined 6 and 24 hours after infection with 6*105 CFU. Data of bacterial loads are
expressed as scatter-plots.
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Ly-6 G positive lung surface, did not significantly differ
between strains.
Splenectomized TLR2/TLR4 double KO mice display an
unaltered host response during pneumococcal pneumonia
Previous studies have suggested that TLR4 contributes
to host defense against S. pneumoniae by virtue of its
capacity to recognize pneumolysin [30,31]. Our labora-
tory recently demonstrated that TLR2 and TLR4 interact
in the recognition of S. pneumoniae and that
pneumolysin-induced TLR4 signalling can compensate for
TLR2 deficiency during pneumococcal pneumonia [12].
We therefore considered it of interest to investigate
whether TLR2/4 double KO mice have an altered
immune response in the absence of a functional spleen.
Thus we infected TLR2/4 double KO mice two weeks
after splenectomy with 4 x 105 CFU of serotype 2 S.
pneumoniae (D39) and determined bacterial loads in
whole lung homogenates and blood 24 hours later. Con-
sistent with our findings in TLR2KO mice, there were no
differences in bacterial loads in the lungs of TLR2/4
double KO and WT mice (Figure 5). Blood cultures were
positive in 5 of 7 mice in both groups (data not shown).
In addition, lung cytokine and chemokine concentrations
obtained from lung homogenates 24 hours after infection
with S. pneumoniae D39 did not differ between WT and
TLR2/4 double KO mice (Table 3), and neither did lung
pathology scores or neutrophil influx (Table 3). These
results demonstrate that the combined action of TLR2
and TLR4 does not contribute to host defense during
pneumococcal pneumonia in mice without a functional
spleen.
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Figure 2 Lung pathology induced by serotype 2 S. pneumoniae. Representative slides of lung tissue obtained at 6 hours (upper panels;
A. WT and B. TLR2KO) and 24 hours (lower panels; D. WT and E. TLR2KO) after infection with 6*105 CFU S. pneumoniae (D39). Haematoxylin and
eosin staining. Magnification 10x. Insets: representative slides of lung Ly-6 G staining (brown), showing influx of neutrophils. Findings are
quantified by total pathology scores (total lung inflammation scores, TLIS) and scores of pulmonary Ly-6 G at 6 hours (C), and 24 hours (F) after
induction of pneumococcal pneumonia. Data are expressed as means ± SE (3–7 mice per group).
Figure 3 TLR2 does not contribute to host defense against serotype 3 S. pneumoniae after splenectomy. Bacterial outgrowth after
infection with serotype 3 S. pneumoniae (ATCC6303) in lungs and blood of WT mice and TLR2KO mice. Bacterial loads were determined 24 hours
after infection with 7*104 CFU. Data are expressed as scatter-plots.
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Discussion
Previous studies have established that TLR2 does not
contribute to an effective antibacterial defense during
pneumococcal pneumonia [8,11-13], suggesting that
other components of the immune system are sufficient
to maintain an adequate response against S. pneumoniae.
We here addressed the question whether an intact
spleen, which plays an important role in the primary
defense against pneumococci, can compensate for TLR2
deficiency during pneumococcal pneumonia, thereby
explaining the insignificant role of TLR2 in the other-
wise immune competent host. To this end, we compared
the host response in asplenic WT and TLR2KO mice
after infection with S. pneumoniae via the airways. We
demonstrate that even in absence of the spleen, TLR2
does not contribute to host defense during pneumonia
with serotype 2 or 3 S. pneumoniae.
Among the different TLR family members implicated
in the immune recognition of S. pneumoniae, TLR2
sticks out as the most prominent [8,28,32]. In addition,
killing and phagocytosis of S. pneumoniae by murine
neutrophils has been reported to be impaired in the
absence of TLR2 [33]. Nonetheless, the contribution of
intact TLR2 signaling to protective immunity against the
pneumococcus seems to depend on the localization of
the primary infection: whereas TLR2 appears not essen-
tial for host defense during pneumonia [8,11-13], this re-
ceptor was reported to protect the host during
meningitis caused by S. pneumoniae [34,35].
We here postulated that the potentially protective
properties of TLR2 in host defense during pneumococcal
pneumonia might become visible if another important
line of defense (i.e. an intact spleen) would be elimi-
nated. In line, our laboratory previously exposed a pro-
tective role for TLR2 during airway infection with a S.
pneumoniae strain deficient for pneumolysin, an intra-
cellular toxin recognized by TLR4, suggesting that
during infection with WT S. pneumoniae TLR2 defi-
ciency can be compensated for by pneumolysin-induced
Table 2 Lung cytokine and chemokine levels in
splenectomized WT and TLR2KO mice 24 hours after
intranasal infection with serotype 3 S. pneumoniae
WT TLR2 KO
TNF-α 1619± 277 1482± 536
IL-1β 261± 53 203± 75
MIP-2 2842 ± 216 2076± 216 *
KC 6767± 2446 4167± 1197
Whole lung homogenates were obtained at 24 hours after intranasal infection
with 7*104 CFU of S. pneumoniae serotype 3 (ATCC). Data are means ± SEM
(N= 7–8 per group).
* indicates p< 0,05 versus WT mice, ** indicate p< 0,005 versus WT mice.
TNF-α, IL-1β, MIP-2 and KC values are in pg/ml.
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Figure 4 Lung pathology induced by serotype 3 S. pneumoniae. Representative slides of lung tissue obtained at 24 hours after infection with
7*104 CFU S. pneumoniae (ATCC), in WT mice (panel A) and TLR2KO mice (panel B).Representative slides of lung tissue obtained at 24 hours after
infection with 7*104 CFU S. pneumoniae (ATCC), in WT mice (panel A) and TLR2KO mice (panel B).Haematoxylin and eosin staining. Magnification
10x. Insets: representative slides of lung Ly-6 G staining (brown), showing influx of neutrophils. Findings are quantified by total pathology scores
(total lung inflammation scores, TLIS) in panel C, and scores of pulmonary Ly-6 G in panel D, at 24 hours after induction of pneumococcal
pneumonia. Data are expressed as means ± SE (3–7 mice per group). ** indicate p = 0,0012.
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TLR4 signaling [12]. The present data clearly show that
even in the hyper-vulnerable asplenic host TLR2 does
not contribute to defense against pneumococcal pneu-
monia, as reflected by similar mortality and bacterial
growth in TLR2KO and WT mice. Of note, even TLR2/
4 double KO mice were not impaired in bacterial con-
trol, which indicates that besides the interaction between
S. pneumoniae and TLR2, the interaction between pneu-
molysin and TLR4 does not stimulate antibacterial
defense in the asplenic host either. We did not investi-
gate non-TLR signaling in this model. Recently, it was
shown that human and murine mononuclear cells re-
spond to S. pneumoniae expressing pneumolysin by pro-
ducing IL-1β via a mechanism that depended on the
NOD-like receptor family, pyrin domain containing 3
(NLRP3) inflammasome. Specifically, release of IL-1β
was induced by wild-type D39 S. pneumoniae but not by
pneumolysin-deficient pneumococci [36], showing a
TLR-4 independent route of pneumolysin signaling.
The current experiments were performed with two dif-
ferent S. pneumoniae serotypes (2 and 3). Although we
did not find differences in bacterial loads between
TLR2KO and WT mice after infection with either
serotype, there was a consistent trend towards lower
levels of inflammation in the lungs of TLR2KO mice, as
determined by semi-quantitative pathology scores of
lung tissue slides. Indeed, 6 and 24 hours after infection
with serotype 2 S. pneumoniae pathology scores were
lower in asplenic TLR2KO mice (albeit not statistically
significant), whereas 24 hours after infection with sero-
type 3 S. pneumoniae TLR2KO mice displayed signifi-
cantly less lung inflammation when compared to WT
mice. These findings corroborate earlier studies from
our laboratory demonstrating a role for TLR2 in the in-
duction of lung inflammation early after induction of
pneumococcal pneumonia in otherwise immune compe-
tent mice [8,12]. Lung cytokine and chemokine levels
were not consistently influenced by TLR2 in asplenic
mice, suggesting that other receptors, including other
TLRs, are sufficient for induction of these inflammatory
mediators.
We used an infectious dose that caused lethality in
virtually all mice beyond the 48 hour time point. We specif-
ically chose this dose considering that overwhelming
pneumococcal infection after splenectomy in humans
causes irreversible infection leading to mortality within the
first 48 hours [17,18,37]. As a consequence, our data do not
exclude a protective role for TLR2 in asplenic animals after
infection with a low nonlethal dose of S. pneumoniae.
Previous studies have implicated TLR9 and MyD88 as
important players in protective immunity in pneumococ-
cal pneumonia [11,38]. We here focused on the role of
TLR2 in defense during S. pneumoniae pneumonia in
the asplenic host, considering that this TLR does not
play a significant part in limiting bacterial growth in ani-
mals with an intact spleen [8,11,12]. Future studies are
warranted to investigate the role of MyD88 and TLR9 in
asplenic animals during respiratory tract infection
caused by the pneumococcus.
Conclusion
It has been well established that splenectomy renders the
host very susceptible to infection with S. pneumoniae. The
Figure 5 TLR2 and TLR 4 do not contribute to host defense against S. pneumoniae after splenectomy. Bacterial outgrowth after infection
with serotype 2 S. pneumoniae (D39) in lungs and blood of WT mice and TLR2x4 double KO mice. Bacterial loads were determined 24 hours after
infection with 4*105 CFU. Data are expressed as scatter-plots.
Table 3 Lung cytokine and chemokine levels and
pathology scores in splenectomized WT and TLR2x4KO
mice 24 hours after intranasal infection with serotype 2 S.
pneumoniae
WT TLR2x4 KO
TNF-α 1260± 209 1399± 227
IL-1β 226 ± 120 207± 62
MIP-2 1731 ± 290 2161± 542
KC 3597± 1536 6058± 3416
TLIS 7,2 ± 2,3 7,3 ± 0,8
Ly-6 G 3,3 ± 0,4 3,6 ± 1,0
Whole lung homogenates were obtained at 24 hours after intranasal infection
with 4*105 CFU of S. pneumoniae. Data are means ± SEM (N= 7 per group).
TNF-α, IL-1β, MIP-2 and KC values are in pg/ml. TLIS = total lung inflammation
score in arbitrary units, as described in the Methods section.
Ly-6 G score = percentage of lung surface that is Ly-6 G positive, see Methods
section.
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results presented here strongly argue against a significant
role of TLR2 in host defense during S. pneumoniae pneu-
monia in the asplenic state. Therefore, in the immune
competent host, there are other components of the im-
mune system than the spleen that can provide a sufficient
backup mechanism for TLR2 deficiency in the defense
against intrapulmonary infections with S. pneumoniae.
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